Torrent Pharmaceuticals Limited (TORNTPHARM) — Board Meeting | 29 July 2025

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

The board approved the audited standalone and consolidated financial statements for March 31, 2025, declared a final dividend of ₹6 per share alongside an interim dividend of ₹26, reappointed Aman Mehta as Managing Director, enhanced borrowing limits to ₹26,000 crore, and approved related resolutions including remuneration and auditor appointments.

📄 View Original Announcement (PDF)

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TORNTPHARM — Free

Free account · 2 AI queries/day